Literature DB >> 8496299

Evidence for increased androsterone metabolism in some normoandrogenic women with acne.

E Carmina1, R A Lobo.   

Abstract

Increased androgen production from the ovary, adrenal or locally in skin has been implicated in the pathogenesis of acne. Recent data have provided evidence that androsterone (Ao) metabolism is exaggerated in acne and serum metabolites of Ao differentiate between acne and hirsutism in hyperandrogenic women. Here we have extended these studies to normoandrogenic women who have moderate to severe acne. We measured serum ovarian and adrenal androgens as well as the glucuronide and sulfate metabolites of Ao and 3 alpha-androstanediol which reflect, in part, peripheral androgen action. In a group of 15 well-selected normoandrogenic patients with acne, both serum Ao glucuronide (G) and Ao were elevated (P < 0.01; P < 0.05). The ratios of Ao G to androgen precursors of both ovarian and adrenal origin were elevated as was the ratio of Ao G/Ao (P < 0.05). These data suggest that increased Ao metabolism is a specific abnormality found in both normoandrogenic and hyperandrogenic women with acne. Our findings also provide a rationale for antiandrogen therapy at least in some normoandrogenic women with acne.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496299     DOI: 10.1210/jcem.76.5.8496299

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.

Authors:  Ronald S Swerdloff; Robert E Dudley; Stephanie T Page; Christina Wang; Wael A Salameh
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

Review 2.  Diagnostic criteria for polycystic ovarian syndrome.

Authors:  F J Broekmans; B C J M Fauser
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

3.  Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience.

Authors:  Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

4.  Anticonvulsant activity of androsterone and etiocholanolone.

Authors:  Rafal M Kaminski; Herbert Marini; Won-Joo Kim; Michael A Rogawski
Journal:  Epilepsia       Date:  2005-06       Impact factor: 5.864

5.  Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.

Authors:  Flaminia Fanelli; Alessandra Gambineri; Marco Mezzullo; Valentina Vicennati; Carla Pelusi; Renato Pasquali; Uberto Pagotto
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

6.  The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne.

Authors:  E Carmina; A J Godwin; F Z Stanczyk; J S Lippman; R A Lobo
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

7.  [Acne tarda. Acne in adults].

Authors:  T Jansen; O E Janßen; G Plewig
Journal:  Hautarzt       Date:  2013-04       Impact factor: 0.751

8.  Clinical, Biochemical, and Hormonal Associations in Female Patients with Acne: A Study and Literature Review.

Authors:  Sujata Mehta-Ambalal
Journal:  J Clin Aesthet Dermatol       Date:  2017-10-01

Review 9.  Adult-onset acne: prevalence, impact, and management challenges.

Authors:  Marco A Rocha; Ediléia Bagatin
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-02-01

10.  ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne.

Authors:  Marco Rocha; Karina H M Cardozo; Valdemir M Carvalho; Edieia Bagatin
Journal:  Dermatoendocrinol       Date:  2017-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.